Editorial board

Editor-in-Chief:

Professor David B Price, Observational and Pragmatic Research Institute, Singapore; Primary Care Respiratory Medicine at the University of Aberdeen, UK

Editorial Board:

Dr Mario Gonzalez de la Parra, Research, Biokinetics, S. A. de C. V., Mexico

Dr John Haughney, Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom

Professor Sabzali Javadov, Physiology, University of Puerto Rico Medical Sciences Campus, United States

Professor Amanda Lee, Institute of Applied Health Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, Scotland, United Kingdom

Professor Kyu Lim, Department of Biochemistry, College of Medicine, Cancer Research Institute, Infection Signaling Network Research Center, Chungnam National University, Korea, Republic of (South)

Professor Christoph Meier, Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital of Basel, Switzerland

Professor Arshag Mooradian, Department of Medicine, University of Florida College of Medicine, United States

Dr Ruth Murray, Director Medscript Ltd NZ & Research Fellow, OPC, Cambridge, UK

Dr Joan B Soriano, MD, PhD, FERS, FCCP. Associate Professor , Respiratory epidemiologist at the Departent of Pneumology of Hospital de la Princesa in Madrid, and teaches undergraduates at Universidad Autónoma de Madrid, Madid, and at Universitat de les Illes Balears, Palma, both in Spain

Dr Job FM van Boven, Associate Professor of Health Economics & Real-World (drug) Outcomes, Department of Clinical Pharmacy & Pharmacology, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Centre Groningen, University of Groningen, The Netherlands